Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Augmented Reality Application

K-Number: K232339 · 2024-02-01

Decision Date2024-02-01
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Augmented Reality Application is a medical device manufactured by Sira Medical, Inc.. It received FDA 510(k) clearance on 2024-02-01 under approval number K232339. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Augmented Reality Application?

Augmented Reality Application is a medical device that received FDA 510(k) clearance on 2024-02-01. It is manufactured by Sira Medical, Inc.. The 510(k) number is K232339.

When was Augmented Reality Application approved by the FDA?

Augmented Reality Application received FDA 510(k) clearance on 2024-02-01, under approval number K232339.

What company makes Augmented Reality Application?

Augmented Reality Application is manufactured by Sira Medical, Inc..

What is the FDA product code for Augmented Reality Application?

The FDA product code for Augmented Reality Application is LLZ.

Related Clinical Trials

Related PubMed Literature

Related Devices (Code: LLZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.